Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:RWLK

ReWalk Robotics (RWLK) Stock Price, News & Analysis

ReWalk Robotics logo

About ReWalk Robotics Stock (NASDAQ:RWLK)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.64
$1.25
52-Week Range
N/A
Volume
303,600 shs
Average Volume
541,468 shs
Market Capitalization
$63.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RWLK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ReWalk Robotics and its competitors with MarketBeat's FREE daily newsletter.

RWLK Stock News Headlines

Lake Street Keeps Their Buy Rating on Rewalk Robotics (LFWD)
Lake Street Sticks to Its Buy Rating for Rewalk Robotics (LFWD)
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
ReWalk Robotics Ltd (2RW.MU)
ReWalk Robotics earnings: here's what Wall Street expects
See More Headlines

RWLK Stock Analysis - Frequently Asked Questions

ReWalk Robotics Ltd. (NASDAQ:RWLK) issued its quarterly earnings results on Thursday, November, 11th. The medical device company reported ($0.06) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.06). The medical device company earned $1.97 million during the quarter, compared to analyst estimates of $1.60 million. ReWalk Robotics had a negative trailing twelve-month return on equity of 29.00% and a negative net margin of 238.35%.

Based on aggregate information from My MarketBeat watchlists, some other companies that ReWalk Robotics investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Calumet (CLMT), Two Harbors Investments (TWO), NVIDIA (NVDA), Meta Platforms (META) and NovoCure (NVCR).

Company Calendar

Last Earnings
11/11/2021
Today
7/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
NASDAQ:RWLK
Fax
N/A
Employees
56
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$19.57 million
Net Margins
-238.35%
Pretax Margin
-233.51%

Debt

Sales & Book Value

Annual Sales
$5.51 million
Price / Cash Flow
N/A
Book Value
$1.10 per share
Price / Book
N/A

Miscellaneous

Free Float
58,764,000
Market Cap
$63.04 million
Optionable
Optionable
Beta
2.30
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:RWLK) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners